METOLOSE®
Other SM´s
Methyl cellulose, different grades 15-4000 mPas USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
Dissolution behavior of various lower viscosity grades [P-014]
English
Film properties of HPMC and MC [G-002]
English
Film properties of low-viscosity grades cellulose derivatives [G-011]
English
Oxygen permeability of low-viscosity grade cellulose derivatives [G-016]
English
Solubility of HPMC and MC in organic solvents [M-004]
English
Taste masking for fine granules by METOLOSE® and an acrylic polymer [M-003]
English
METOLOSE®
60SH´s
Hypromellose 2910, different viscosities 50-10000 mPas USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
Dissolution behavior of various lower viscosity grades [P-014]
English
Film properties of HPMC and MC [G-002]
English
Film properties of low-viscosity grades cellulose derivatives [G-011]
English
Oxygen permeability of low-viscosity grade cellulose derivatives [G-016]
English
Solubility of HPMC and MC in organic solvents [M-004]
English
Taste masking for fine granules by METOLOSE® and an acrylic polymer [M-003]
English
METOLOSE®
90SH´s
Hypromellose 2208, different viscosities 4000-100000 mPas USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
Dissolution behavior of various lower viscosity grades [P-014]
English
Film properties of HPMC and MC [G-002]
English
Film properties of low-viscosity grades cellulose derivatives [G-011]
English
Oxygen permeability of low-viscosity grade cellulose derivatives [G-016]
English
Solubility of HPMC and MC in organic solvents [M-004]
English
Taste masking for fine granules by METOLOSE® and an acrylic polymer [M-003]
English
METOLOSE® SR
90SH-100SR
Hypromellose 2208, 100 mPas, sustained release USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE SR®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
A study on the robustness of the wet granulation process to prepare metformin HCL extended-release matrix tablet using METOLOSE® 90SH-15000SR [SR-006]
English
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
English
Coating application of METOLOSE® in extended release pellet formulation [SR-020]
English
Coating application of METOLOSE® in sustained release tablets [SR-019]
English
Comparative study of dissolutions from matrix tablets with METOLOSE® SR by different preparation methods [SR-012]
English
Comparison between direct compression and wet granulation in hydrophilic matrix tablet using METOLOSE® SR [SR-001]
English
Formulation of metformin HCl sustained release tablets [SR-018]
English
Formulation of paracetamol bilayer tablet (dose: 650 mg) [SR-017]
English
Impact of combination of METOLOSE®SR grades in Carbamazepine extended release matrix tablet formulation [SR-021]
English
Particle size analysis of METOLOSE® SR with various laser analysers [SR-010]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Acetaminophen) [SR-014]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Metformin) [SR-011]
English
QbD (Quality by Design) approach to the formulation of hydrophylic matrix tablets using METOLOSE® SR (Dipyridamole) [SR-009]
English
Solvent selection in wet granulation for hydrophilic matrix tablets using METOLOSE® SR [SR-003]
English
The effect of CMCNa on the dissolution profiles of hydrophylic matrix tablets containg METOLOSE® SR [SR-008]
English
The effect of glidant of hydrophilic matrix tablets containing METOLOSE® SR [SR-015]
English
The effect of the solubility of APIs on the dissolution profiles of hydrophylic matrix tablets containing METOLOSE® SR [SR-007]
English
METOLOSE® SR
90SH-4000SR
Hypromellose 2208, 4000 mPas, sustained release USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE SR®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
A study on the robustness of the wet granulation process to prepare metformin HCL extended-release matrix tablet using METOLOSE® 90SH-15000SR [SR-006]
English
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
English
Coating application of METOLOSE® in extended release pellet formulation [SR-020]
English
Coating application of METOLOSE® in sustained release tablets [SR-019]
English
Comparative study of dissolutions from matrix tablets with METOLOSE® SR by different preparation methods [SR-012]
English
Comparison between direct compression and wet granulation in hydrophilic matrix tablet using METOLOSE® SR [SR-001]
English
Formulation of metformin HCl sustained release tablets [SR-018]
English
Formulation of paracetamol bilayer tablet (dose: 650 mg) [SR-017]
English
Impact of combination of METOLOSE®SR grades in Carbamazepine extended release matrix tablet formulation [SR-021]
English
Particle size analysis of METOLOSE® SR with various laser analysers [SR-010]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Acetaminophen) [SR-014]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Metformin) [SR-011]
English
QbD (Quality by Design) approach to the formulation of hydrophylic matrix tablets using METOLOSE® SR (Dipyridamole) [SR-009]
English
Solvent selection in wet granulation for hydrophilic matrix tablets using METOLOSE® SR [SR-003]
English
The effect of CMCNa on the dissolution profiles of hydrophylic matrix tablets containg METOLOSE® SR [SR-008]
English
The effect of glidant of hydrophilic matrix tablets containing METOLOSE® SR [SR-015]
English
The effect of the solubility of APIs on the dissolution profiles of hydrophylic matrix tablets containing METOLOSE® SR [SR-007]
English
METOLOSE® SR
90SH-15000SR
Hypromellose 2208, 15000 mPas, sustained release USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE SR®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
A study on the robustness of the wet granulation process to prepare metformin HCL extended-release matrix tablet using METOLOSE® 90SH-15000SR [SR-006]
English
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
English
Coating application of METOLOSE® in extended release pellet formulation [SR-020]
English
Coating application of METOLOSE® in sustained release tablets [SR-019]
English
Comparative study of dissolutions from matrix tablets with METOLOSE® SR by different preparation methods [SR-012]
English
Comparison between direct compression and wet granulation in hydrophilic matrix tablet using METOLOSE® SR [SR-001]
English
Formulation of metformin HCl sustained release tablets [SR-018]
English
Formulation of paracetamol bilayer tablet (dose: 650 mg) [SR-017]
English
Impact of combination of METOLOSE®SR grades in Carbamazepine extended release matrix tablet formulation [SR-021]
English
Particle size analysis of METOLOSE® SR with various laser analysers [SR-010]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Acetaminophen) [SR-014]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Metformin) [SR-011]
English
QbD (Quality by Design) approach to the formulation of hydrophylic matrix tablets using METOLOSE® SR (Dipyridamole) [SR-009]
English
Solvent selection in wet granulation for hydrophilic matrix tablets using METOLOSE® SR [SR-003]
English
The effect of CMCNa on the dissolution profiles of hydrophylic matrix tablets containg METOLOSE® SR [SR-008]
English
The effect of glidant of hydrophilic matrix tablets containing METOLOSE® SR [SR-015]
English
The effect of the solubility of APIs on the dissolution profiles of hydrophylic matrix tablets containing METOLOSE® SR [SR-007]
English
METOLOSE® SR
90SH-100000SR
Hypromellose 2208, 100000 mPas, sustained release USP, EP, JP Japan
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
METOLOSE SR®
English
Pharmaceutical Excipients
English
Safety Data Sheets
Safety Data Sheet
English
Technical Information
A study on the robustness of the wet granulation process to prepare metformin HCL extended-release matrix tablet using METOLOSE® 90SH-15000SR [SR-006]
English
Bilayer tablets using L-HPC and METOLOSE® SR [SR-005]
English
Coating application of METOLOSE® in extended release pellet formulation [SR-020]
English
Coating application of METOLOSE® in sustained release tablets [SR-019]
English
Comparative study of dissolutions from matrix tablets with METOLOSE® SR by different preparation methods [SR-012]
English
Comparison between direct compression and wet granulation in hydrophilic matrix tablet using METOLOSE® SR [SR-001]
English
Formulation of metformin HCl sustained release tablets [SR-018]
English
Formulation of paracetamol bilayer tablet (dose: 650 mg) [SR-017]
English
Impact of combination of METOLOSE®SR grades in Carbamazepine extended release matrix tablet formulation [SR-021]
English
Particle size analysis of METOLOSE® SR with various laser analysers [SR-010]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Acetaminophen) [SR-014]
English
QbD (Quality by Design) approach for the formulation of hydrophylic matrix tablets using METOLOSE® SR (Metformin) [SR-011]
English
QbD (Quality by Design) approach to the formulation of hydrophylic matrix tablets using METOLOSE® SR (Dipyridamole) [SR-009]
English
Solvent selection in wet granulation for hydrophilic matrix tablets using METOLOSE® SR [SR-003]
English
The effect of CMCNa on the dissolution profiles of hydrophylic matrix tablets containg METOLOSE® SR [SR-008]
English
The effect of glidant of hydrophilic matrix tablets containing METOLOSE® SR [SR-015]
English
The effect of the solubility of APIs on the dissolution profiles of hydrophylic matrix tablets containing METOLOSE® SR [SR-007]
English
TYLOPUR®
60SH-50
Hypromellose 2910, 50 mPas USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
Pharmaceutical Excipients
English
TYLOPUR®
English
Safety Data Sheets
Tylopur 60SH-50
Please select
German
English
TYLOPUR®
60SH-4000
Hypromellose 2910, 4000 mPas USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Safety Data Sheets
Tylopur 60SH-4000
Please select
German
English
TYLOPUR® SR
90SH-100SR
Hypromellose 2208, 100 mPas, sustained release USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
Pharmaceutical Excipients
English
Safety Data Sheets
Tylopur 90SH-100SR
Please select
German
English
TYLOPUR®
60SH-13000
Hypromellose 2910, 13000 mPas USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Safety Data Sheets
Tylopur 60SH-10000
Please select
German
English
TYLOPUR® SR
90SH-4000SR
Hypromellose 2208, 4000 mPas, sustained release USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
Pharmaceutical Excipients
English
Safety Data Sheets
Tylopur 90SH-4000SR
Please select
German
English
TYLOPUR® SR
90SH-15000SR
Hypromellose 2208, 15000 mPas, sustained release USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
Pharmaceutical Excipients
English
Safety Data Sheets
Tylopur 90SH-15000SR
Please select
German
English
TYLOPUR® SR
90SH-100000SR
Hypromellose 2208, 100000 mPas, sustained release USP, EP, JP, EXCiPACT Germany
Suitable
SelectRelated documents Languages Available as Download or Request Brochures
Guide to Applications
English
Pharmaceutical Excipients
English
Safety Data Sheets
Tylopur 90SH-100000SR
Please select
German
English